Clinical trial
Study Evaluating GAP-486 in Non-sustained Ventricular Tachycardia
NCT00124891 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00124891 |
|---|---|
| Title | Study Evaluating GAP-486 in Non-sustained Ventricular Tachycardia |
| Official title | Study Evaluating Subjects With Non-sustained Ventricular Tachycardia |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arrhythmias |
| Intervention type | Drug |
| Interventions | Double-blind investigational anti-arrhythmic, GAP-486 |
| Enrollment | 500 |
| Start date | Jun 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Jul 28, 2005 |
| Last update posted | May 3, 2022 |
| Countries | Brazil, Canada, Croatia, Denmark, Hungary, India, Italy, Mexico, Poland, Romania, Russia, Serbia and 4 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: